Concepedia

Bing Xie

BX

Statistics

Publications

9

Citations

258

H-Index

9

Active since

2019

Affiliations

National Institute on Drug Abuse(Current)

National Institutes of Health

Cornell University

Memorial Sloan Kettering Cancer Center

Bing Xie is an author at National Institute on Drug Abuse specializing in pharmacology, medicine, and medicinal chemistry.

ORCID

Publications per year

2019–2023

9

Publications

9

GPCR-mediated β-arrestin activation deconvoluted with single-molecule precision

Wesley B. Asher, Daniel S. Terry, G. Glenn Gregorio et al. · Cell · 2022 · 109 citations · Full text

, , +17

Pharmacological Characterization of the Imipridone Anticancer Drug ONC201 Reveals a Negative Allosteric Mechanism of Action at the D2 Dopamine Receptor

R. Benjamin Free, Caroline A. Cuoco, Bing Xie et al. · Molecular Pharmacology · 2021 · 40 citations · Full text

, , +14

A comprehensive evaluation of the potential binding poses of fentanyl and its analogs at the µ-opioid receptor

Bing Xie, Alexander Goldberg, Lei Shi · Computational and Structural Biotechnology Journal · 2022 · 26 citations · Full text

, , +17

Chirality of Novel Bitopic Agonists Determines Unique Pharmacology at the Dopamine D3 Receptor

Pramisha Adhikari, Bing Xie, Ana Semeano et al. · Biomolecules · 2021 · 22 citations · Full text

, , +17

Binding preference at the μ-opioid receptor underlies distinct pharmacology of cyclopropyl versus valeryl analogs of fentanyl

Bing Xie, Valerie P. Le Rouzic, Alexander Goldberg et al. · Neuropharmacology · 2023 · 18 citations · Full text

, , +12

1–5 of 9